ReWalk Robotics Ltd. (NASDAQ:RWLK) shares saw unusually-high trading volume on Friday . Approximately 52,900 shares traded hands during trading, a decline of 5% from the previous session’s volume of 55,701 shares.The stock last traded at $7.08 and had previously closed at $7.02.

RWLK has been the subject of a number of recent research reports. Zacks Investment Research raised ReWalk Robotics from a “sell” rating to a “hold” rating in a research report on Thursday, April 28th. Jefferies Group reaffirmed a “buy” rating and set a $16.00 price target on shares of ReWalk Robotics in a research report on Sunday, May 8th. Finally, Piper Jaffray Cos. initiated coverage on ReWalk Robotics in a research report on Friday. They set an “overweight” rating and a $10.00 price target for the company. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. ReWalk Robotics presently has a consensus rating of “Buy” and a consensus target price of $12.80.

The company’s market capitalization is $86.97 million. The company’s 50 day moving average is $6.92 and its 200-day moving average is $9.18.

ReWalk Robotics (NASDAQ:RWLK) last posted its quarterly earnings data on Thursday, May 5th. The medical device company reported ($0.48) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.60) by $0.12. The company earned $2.06 million during the quarter, compared to analyst estimates of $1.56 million. During the same period in the prior year, the firm earned ($0.48) earnings per share. ReWalk Robotics’s revenue was up 224.6% compared to the same quarter last year. On average, analysts forecast that ReWalk Robotics Ltd. will post ($2.11) earnings per share for the current year.

In other ReWalk Robotics news, major shareholder Scp Vitalife Partners Ii Lp sold 20,256 shares of ReWalk Robotics stock in a transaction that occurred on Thursday, May 26th. The stock was sold at an average price of $8.69, for a total value of $176,024.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Scp Vitalife Partners (Israel) sold 4,043 shares of ReWalk Robotics stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $9.09, for a total value of $36,750.87. The disclosure for this sale can be found here.

An institutional investor recently bought a new position in ReWalk Robotics stock. EAM Investors LLC bought a new position in ReWalk Robotics Ltd. (NASDAQ:RWLK) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 93,333 shares of the medical device company’s stock, valued at approximately $1,351,000. EAM Investors LLC owned approximately 0.77% of ReWalk Robotics at the end of the most recent quarter.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.